Virtual Network's Login.
CONFERENCE'S LEARNING OBJECTIVES
Upon completion of this CME activity, participants should be able to:
• Understand recent advances in elucidating the pathogenesis of CLL
• Describe recent data on therapeutic regimens for CLL
• Understand emerging data on mechanisms of resistance to targeted agents in CLL
• Understand the debate about how best to optimize CLL therapy in the future
About the Conference:
The 3rd ESH Tranlational Research Conference on CHRONIC LYMPHOCYTIC LEUKAEMIA is proposing a programme of leading-edge basic and clinical science where a panel of global experts in the field will provide numerous opportunities for formal and informal interactions to discuss the present and the future of CLL research. It is open to an international audience of biologists and clinicians, particularly welcoming those in-training.
This translational research conference will explore the most recent advances in the understanding of the pathogenesis and clinical management of the disease. Open and spirited discussion on the most up-to-date information in the field is expected to understand how the many new biologic insights apply to the future of CLL.
The programme will include:
Plenary Sessions - Simultaneous Meet the Experts Sessions - Brief Oral Communications - Mentored Poster Walk - Ample time for in-depth discussion.
CALL FOR ABSTRACT
for Brief Oral Communications or Poster Presentations
Deadline: December 14th, 2023
For more information, click here!
